Press releaseGlobe Newswire
Jasper Therapeutics
JSPR · NASDAQ
$0.4999+$0.0225 (+4.71%)TodayMarket closed ·
Prev close $0.4774
Latest news
- Press releaseGlobe Newswire
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
- Press releaseGlobe Newswire
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
- Press releaseGlobe Newswire
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- NewsAvi Kapoor
Why Dell Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseGlobe Newswire
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsCaroline Ryan
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives
- NewsVandana Singh
Jasper Closes Kira Deal, Extends Cash Runway
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releaseGlobe Newswire
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
- NewsCaroline Ryan
Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate
- Press releaseGlobe Newswire
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseGlobe Newswire
Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
- Press releaseGlobe Newswire
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
- NewsVandana Singh
Jasper Stock Jumps After Promising New Asthma Study Results
- News
Market-Moving News for December 2nd
- Press releaseGlobe Newswire
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
- Press releaseGlobe Newswire
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
- Press releaseGlobe Newswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Driven Brands and Jasper Therapeutics on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- Press releaseBusiness Wire
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
- Press releaseGlobe Newswire
Portnoy Law Firm Announces Class Action on Behalf of Jasper Therapeutics, Inc. Investors
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Stockholders of Jasper, KBR, Spirit, and Molina of the Upcoming Deadlines and Urges Investors to Contact the Firm
- Press releaseBusiness Wire
Deadline Soon: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
- Press releasePRNewswire
JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
- Press releasePRNewswire
JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR
- Press releasePRNewswire
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- Press releasePRNewswire
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR
- Press releasePRNewswire
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Press releasePRNewswire
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Press releasePRNewswire
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- Press releasePRNewswire
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - JSPR
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of Jasper, KBR, Spirit, and Molina to Contact the Firm About their Rights
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.